Skip to Main Content

WASHINGTON — One of the first big issues Scott Gottlieb will have to weigh in on if confirmed as Food and Drug commissioner is what to do about the booming field of diagnostic tests.

Gottlieb, a physician and libertarian scholar, has been lukewarm on whether to regulate in vitro clinical tests, a category that includes finished products such as test kits and platforms as well as laboratory developed tests (LDTs), which are lab protocols used for diagnostics.


He equivocated in a November 2015 talk, sponsored by the American Journal of Managed Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!